Company: RNGE
Filing Date: 2025-03-31
Form Type: 424B3
Source: 0001641172-25-001863
Chunk: 72

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 424B3
Chunk 72
---
 | Quoted                                                                                                     
 market prices in active markets for identical assets or liabilities                                        |
| ● | Level 
 2:    | Inputs                                                                                                     
 to the valuation methodology include:                                                                      |
|   | ○     | Quoted                                                                                                     
 prices for similar assets or liabilities in active markets;                                                |
|   | ○     | Quoted                                                                                                     
 prices for identical assets or similar assets or liabilities in inactive markets;                          |
|   | ○     | Inputs                                                                                                     
 other than quoted prices that are observable for the asset or liability;                                   |
|   | ○     | Inputs                                                                                                     
 that are derived principally from or corroborated by observable market data by correlation or other means. |
| ● | Level 
 3:    | Unobservable                                                                                               
 inputs that are not corroborated by market data                                                            |

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The following is a description of the valuation methodologies used for instruments measured at fair value, including the general classification of such instruments pursuant to the valuation hierarchy.

The equipment held for sale is carried at the lower of carrying amount or fair value, and is considered level 2 as it is based on market prices for similar assets.

Segments

As of December 31, 2024, the Company has five operating business segments: (i) Range Reclaim; (ii) Range Minerals; (iii) Range Water; (iv) Range Security; and (v) Range Land. Previously, beginning in October 2021, the Company began operating under two segments: (A) the Drug Development segment, which reported the operating results of the Company’s broad portfolio of glycosylated cannabinoid prodrugs operating under the name Graphium Biosciences, and (B) the Range Reclaim segment, which reported the operating results of our land reclamation, water restoration and incidental coal mining services to customers throughout Appalachia. The Range Water, Range Security and Range Land business segments began operations in 2023. Beginning in January 2024, Range Minerals, which was previously reported within the Range Reclaim operating business segment, was separately reported as its own operating business segment focused on coal mining using subcontractors and related reclamation activities, and the Drug Development segment was renamed Graphium Biosciences. Graphium Biosciences was sold in September 2024 and therefore the drug development business segment named Graphium Biosciences is no longer reported as an